Barber Daniel 4

What Happened

• Daniel Barber, President and CEO of Aquestive Therapeutics (AQST), disposed of 25,000 shares on 2026-06-15 in an open-market/private sale. The weighted average sale price was $4.1604, resulting in proceeds of approximately $104,010. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-06-15; Form 4 filed 2026-06-16 (appears timely).
• Price range reported: $4.14 to $4.235 per share; weighted average $4.1604.
• Shares disposed: 25,000; proceeds ≈ $104,010.
• Shares owned after the transaction: not provided in the information you supplied.
• Footnote: Reporting person offered to provide, upon request by the SEC staff, the issuer, or a security holder, the number of shares sold at each separate price (i.e., breakdown by individual trade prices).
• Transaction code: S (sale).

Context

• Sales by executives can be routine (diversification, liquidity, tax reasons) and do not alone indicate a change in company fundamentals. No evidence in this filing of a 10b5‑1 plan, gift, or option exercise — the filing reports a straightforward sale.